SEER is an authoratitive source of information on cancer incidence and survival in the United States. SEER currently collects and publishes cancer incidence and survival data from population-based cancer registries covering approximately 28 percent of the U.S. population.
Lymphoproliferative disorders (LPD) refer to several conditions in which lymphocytes are produced in excessive quantities. They are characterized by the abnormal proliferation of lymphocytes into a monoclonal lymphocytosis. Individuals who have some sort of immunodysfunction are susceptible to developing LPD.
Corresponding ICD-9 Codes
238.79 Other lymphatic and hematopoietic tissues
Corresponding ICD-10 Codes
D47.9 Neoplasm of uncertain or unknown behavior of lymphoid, hematopoietic, and related tissue, unspecified
Corresponding ICD-10-CM Codes
(effective October 1, 2015 U.S. only)
D47.9 Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue